Extraordinary General Meeting of Active Biotech AB
Extraordinary General Meeting of Active Biotech was held on March 19, 2018. The meeting resolved, in accordance with the board’s proposal, on a share issue with pre-emptive rights for existing shareholders, of approximately SEK 48 million, before issue costs. Through the rights issue, not more than 48,412,160 new shares are issued. Two existing shares entitle to subscription for one new share. The rights issue is covered by subscription commitments and issue guarantee of approximately SEK 30 million, corresponding to approximately 61 percent of the rights issue.